Skip to main content
. 2022 Jul 7;97(5):606–611. doi: 10.1016/j.abd.2021.09.011

Table 3.

Systemic treatment regimens preferred in each group.

Systemic therapy EN group, n (%) Non-EN group, n (%) p
None 22 (71.0) 50 (54.9) 0.117
Oral corticosteroids alone 5 (16.1) 34 (37.4) 0.029
Oral corticosteroids + azathioprine 1 (3.2) 4 (4.4) NS
Oral corticosteroids + pentoxifylline 3 (9.7) 2 (2.2) NS
Oral corticosteroids + azathioprine + pentoxifylline + infliximab 0 (0.0) 1 (1.1) NS

NS, Not Significant.